Bayer AG NA Stock in the Strategy Check

2.7

Low MatchStockScorer score

Compared with its sector, strongest in Momentum and weakest in Balance sheet & risk.

Sector profile

Sector rank: 44.3 of 100
Average of the axes, measured against the large and mid caps of the sector in developed markets. 100 means ahead of that peer group in every area.

18Strategies checked

How does Bayer AG NA stock perform across 18 strategies?

Excerpt from 18 strategies checked. The full evaluation is visible after a free sign-up.

Mohanram G-Score: Growth QualityFor growth stocks, the substance check shows what is real investment and what is only an announcement.
Low
Piotroski F-Score (9-Point Check)Nine hard balance-sheet criteria separate substance from a downward spiral.
Low
Growth Momentum (CAN SLIM principle)Strong earnings growth, confirmed by the price trend. The bet is on strength, not weakness.
Medium
Earnings Quality: Accrual Check (Sloan)Are the profits real? The Sloan ratio shows book profits that are not backed by cash.
High
Magic Formula: Value + QualityGood companies at cheap prices: two factors, one score.
High
Trending Value: Value + MomentumGet in cheap, but only once the market starts to turn.
Medium

12 more strategies locked

With a free account, you can see the match across all strategies checked in one complete overview.

Open complete overview

Bayer AG NA key metrics: P/E, P/B and equity ratio

Selected fundamental metrics for Bayer AG NA.

P/E ratio-22.6

P/B ratio1.9

Return on equity (ROE)-14.0 %

Equity ratio23.5 %

Debt-to-equity (D/E)1.44

Dividend yield0.2 %

Unlock further metrics

Unlock for free →

Peer comparison

Put the company in its peer context

Compare the displayed overall score with the unlocked peer rows on this page.

Bounded preview

Comparison view

Bayer AG NA2.7

Peer median6.4

Based on 3 unlocked peers from this page, not on the entire sector.

Similar stocks in Healthcare

How comparable stocks in the same sector score in the StockScorer model.

Symbol	Company	Rating
BAYN.DE	Bayer AG NAthis page
LLY	Eli Lilly and Company	Medium6.4
JNJ	Johnson & Johnson	Medium6.4
LLY.TO	Eli Lilly CDR (CAD Hedged)	Medium6.4
ABBV	AbbVie Inc	locked
MRK	Merck & Company Inc	locked

Unlock the full peer comparison →

Bayer AG NA stock at a glance

Bayer AG NA stock (BAYN.DE) is evaluated entirely rule-based in the StockScorer model. It currently reaches a StockScorer score of 2.7 out of 10, which corresponds to a low match with the underlying strategies. The classification is deliberately neutral and is not a recommendation to buy, hold or sell.

What counts here is price momentum, meaning relative strength and trend versus the broader market. Fundamental criteria come from the remaining strategies among the 18 checked, including quality, value and dividend approaches.

Sector classification: Healthcare

Bayer AG NA is assigned to the Healthcare sector. The sector classification makes it possible to compare the stock with peers from the same sector, for example in the peer comparison further up this page.

Frequently asked questions about Bayer AG NA stock

How does Bayer AG NA stock (BAYN.DE) score in the StockScorer model?

Bayer AG NA stock reaches a StockScorer score of 2.7 out of 10, which is a low match with the rule-based strategies. It fits the Momentum category best. All values are purely rule-based and updated every business day.

What is Bayer AG NA's P/E ratio?

Bayer AG NA stock currently has a P/E ratio of -22.6, a P/B ratio of 1.9, an equity ratio of 23.5 % and a return on equity (ROE) of -14.0 %.

What sector is Bayer AG NA in?

Bayer AG NA is assigned to the Healthcare sector. StockScorer uses the sector classification, among other things, to relate the stock to comparable peers from the same sector.

Keep exploring

Unlock the full analysis for free

Signed up in 30 seconds. Free, cancel anytime.

✓ More metrics: margin, debt, cash flow and more
✓ Full peer comparison within the same sector
✓ See the match across all strategies in detail
✓ Apply your own scoring profile to any stock
✓ Add the stock to your watchlist and track score changes
✓ Daily updated ratings for 500+ stocks

Start for free →Already registered? Log in now

Not investment advice. The match shown reflects rule-based criteria and is not a recommendation to buy, hold or sell. Further metrics are available after a free sign-up.

Learn more about the metrics in the metrics glossary or all rated stocks in the stock overview.

How StockScorer rates every stock is explained on the methodology page.